0001209191-19-026937.txt : 20190502 0001209191-19-026937.hdr.sgml : 20190502 20190502132106 ACCESSION NUMBER: 0001209191-19-026937 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170901 FILED AS OF DATE: 20190502 DATE AS OF CHANGE: 20190502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Irving Bryan CENTRAL INDEX KEY: 0001715542 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 19791010 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2017-09-01 2017-09-05 1 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001715542 Irving Bryan 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Chief Scientific Officer This amendment is being filed to attach the reporting person's Power of Attorney, which was inadvertently omitted from the reporting person's original Form 3 filed with the Securities and Exchange Commission on September 5, 2017 (the "Original Form 3"). No other changes are being made to the Original Form 3. Exhibit List: Exhibit 24 - Power of Attorney /s/ Francis Sarena, Attorney-in-fact 2019-05-02 EX-24 2 attachment1.htm EX-24 DOCUMENT

					Exhibit 24

		Power of Attorney

      The undersigned, hereby constitutes and appoints Marc Belsky and Francis
Sarena, and each of them, for so long as such person is an officer of Five Prime
Therapeutics, Inc., a Delaware corporation ("FivePrime"), and Laura Berezin, for
so long as she is a partner of a law firm representing FivePrime, the
undersigned's true and lawful attorney-in-fact, with full power of substitution
and resubstitution, each with the power to act alone for the undersigned and in
the undersigned's name, place and stead, to:

	1. Complete and execute Forms 3, 4 and 5 under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), and other forms and all amendments
thereto on the undersigned's behalf as such attorney-in-fact shall in his
discretion determine to be required or advisable pursuant to Section 16 of the
Exchange Act and the rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of the undersigned's beneficial
ownership of securities of FivePrime or changes in such beneficial ownership;
and

	2. Do all acts necessary in order to file such forms and amendments with the
Securities and Exchange Commission, any securities exchange or national
association, FivePrime and such other persons or agencies as the
attorney-in-fact shall deem appropriate.

      The undersigned hereby ratifies and confirms all that said
attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is
FivePrime assuming, any of the undersigned's responsibilities to comply with or
liability under Section 16 of the Exchange Act or any rules and regulations
promulgated thereunder or any successor laws and regulations.

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's beneficial ownership of securities of FivePrime or changes in such
beneficial ownership, unless earlier revoked by the undersigned in a signed
writing delivered to FivePrime and to the foregoing attorneys-in-fact.

      The undersigned has executed this Power of Attorney as of September 1,
2017.


/s/ Bryan Irving
Bryan Irving